We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
AACR 2024 presents advancements in pancreatic and gastric cancers: Promising evidence has been found for the therapeutic potential of a neoantigen‐based cancer vaccine used in the adjuvant setting.
- Authors
Nierengarten, Mary Beth
- Abstract
This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, more promising evidence for the therapeutic potential of a neoantigen–based cancer vaccine used in the adjuvant setting is reported from the American Association for Cancer Research 2024 meeting. In addition, articles address a significant overall survival benefit with dostarlimab plus chemotherapy in advanced endometrial cancer, and a favorable overall survival trend with pembrolizumab plus chemotherapy for endometrial cancer.
- Subjects
CANCER vaccines; STOMACH cancer; PANCREATIC cancer; ENDOMETRIAL cancer; OVERALL survival
- Publication
Cancer (0008543X), 2024, Vol 130, Issue 13, p2244
- ISSN
0008-543X
- Publication type
Article
- DOI
10.1002/cncr.35371